HK1209638A1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
HK1209638A1
HK1209638A1 HK15110448.0A HK15110448A HK1209638A1 HK 1209638 A1 HK1209638 A1 HK 1209638A1 HK 15110448 A HK15110448 A HK 15110448A HK 1209638 A1 HK1209638 A1 HK 1209638A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
HK15110448.0A
Other languages
English (en)
Chinese (zh)
Inventor
Shenshen Cai
Brian Alvin Johns
Andrew Spaltenstein
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of HK1209638A1 publication Critical patent/HK1209638A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
HK15110448.0A 2012-12-14 2015-10-23 Pharmaceutical compositions HK1209638A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261737177P 2012-12-14 2012-12-14
PCT/US2013/075196 WO2014093941A1 (fr) 2012-12-14 2013-12-14 Compositions pharmaceutiques

Publications (1)

Publication Number Publication Date
HK1209638A1 true HK1209638A1 (en) 2016-04-08

Family

ID=50935020

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110448.0A HK1209638A1 (en) 2012-12-14 2015-10-23 Pharmaceutical compositions

Country Status (20)

Country Link
US (2) US9795619B2 (fr)
EP (1) EP2931285A4 (fr)
JP (1) JP2016503030A (fr)
KR (1) KR20150093819A (fr)
CN (1) CN104902905A (fr)
AU (1) AU2013358897B2 (fr)
BR (1) BR112015013695A2 (fr)
CA (1) CA2893959A1 (fr)
CL (1) CL2015001660A1 (fr)
CR (1) CR20150313A (fr)
EA (1) EA201590862A1 (fr)
HK (1) HK1209638A1 (fr)
IL (1) IL238807A0 (fr)
MA (1) MA38182A1 (fr)
MX (1) MX2015007563A (fr)
PE (1) PE20151326A1 (fr)
PH (1) PH12015501156A1 (fr)
SG (2) SG11201503807TA (fr)
WO (1) WO2014093941A1 (fr)
ZA (1) ZA201503594B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3387B1 (ar) 2011-12-16 2019-03-13 Glaxosmithkline Llc مشتقات بيتولين
KR20150093819A (ko) * 2012-12-14 2015-08-18 글락소스미스클라인 엘엘씨 약제 조성물
MD4841B1 (ro) 2012-12-21 2023-01-31 Gilead Sciences, Inc. Compuşi policiclici de carbamoilpiridonă şi utilizarea lor farmaceutică
WO2014105926A1 (fr) 2012-12-31 2014-07-03 Hetero Research Foundation Nouveaux dérivés proline de l'acide bétulinique utilisés comme inhibiteurs du vih
EP3252058B1 (fr) 2013-07-12 2021-01-20 Gilead Sciences, Inc. Composés polycycliques-carbamoylpyridone et leur utilisation pour le traitement des infections par vih
NO2865735T3 (fr) 2013-07-12 2018-07-21
TW201613936A (en) 2014-06-20 2016-04-16 Gilead Sciences Inc Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
NO2717902T3 (fr) 2014-06-20 2018-06-23
TWI744723B (zh) 2014-06-20 2021-11-01 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成
US20170129916A1 (en) 2014-06-26 2017-05-11 Hetero Research Foundation Novel betulinic proline imidazole derivatives as hiv inhibitors
MX2017003928A (es) * 2014-09-26 2017-06-28 Glaxosmithkline Intellectual Property (No 2) Ltd Composiciones farmaceuticas de accion prolongada.
TWI738321B (zh) 2014-12-23 2021-09-01 美商基利科學股份有限公司 多環胺甲醯基吡啶酮化合物及其醫藥用途
MA40886B1 (fr) 2015-02-09 2020-03-31 Hetero Research Foundation Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih
WO2016147099A2 (fr) 2015-03-16 2016-09-22 Hetero Research Foundation Nouveaux triterpénone c-3 avec des dérivés amide c-28 servant d'inhibiteurs de vih
SG11201707905WA (en) 2015-04-02 2017-10-30 Gilead Sciences Inc Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
WO2018042331A1 (fr) * 2016-08-31 2018-03-08 Glaxosmithkline Intellectual Property (No.2) Limited Combinaisons, utilisations et traitements correspondants
WO2018042332A1 (fr) * 2016-08-31 2018-03-08 Glaxosmithkline Intellectual Property (No.2) Limited Combinaisons, utilisations et traitements correspondants
WO2019016732A1 (fr) 2017-07-21 2019-01-24 Viiv Healthcare Company Régimes pour le traitement des infections du vih et du sida

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8815265D0 (en) 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US5358721A (en) * 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
AU2001262489A1 (en) 2000-05-23 2001-12-03 Univerzita Karlova V Praze Triterpenoid derivatives
US7163700B2 (en) * 2001-07-31 2007-01-16 Capricorn Pharma, Inc. Amorphous drug beads
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
US20060019934A1 (en) 2004-05-20 2006-01-26 Saxena Brij B Anti-HIV-1 activity of betulinol derivatives
TW200628161A (en) 2004-11-12 2006-08-16 Panacos Pharmaceuticals Inc Novel betulin derivatives, preparation thereof and use thereof
CN1682740A (zh) * 2005-03-11 2005-10-19 中国药科大学 五环三萜类化合物在制备糖原磷酸化酶抑制剂中的应用
EP1869063A2 (fr) 2005-03-29 2007-12-26 Regents Of The University Of Minnesota Procedes de production d'esters 3 bioactif d'aldehyde betulinique et d'acide betulinique
TWI457136B (zh) 2005-04-04 2014-10-21 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
WO2006117666A2 (fr) * 2005-04-29 2006-11-09 Pfizer Inc. Formes posologques, compositions pharmaceutiques et methodes d'administration sous la capsule de tenon
EP1986654A2 (fr) 2006-02-21 2008-11-05 Achillion Pharmaceuticals, Inc. Taraxastanes substitués utiles dans le traitement d'infections virales
FI121468B (fi) 2006-06-07 2010-11-30 Valtion Teknillinen Betuliiniperäiset yhdisteet antimikrobisina aineina
MX2009000158A (es) 2006-06-23 2009-01-23 Tibotec Pharm Ltd Suspensiones acuosas de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil ]-amino]-2-pirimidinil]-amino]-benzonitrilo.
WO2008127364A2 (fr) 2006-10-13 2008-10-23 Myriad Genetics, Inc. Composés antiviraux et utilisation de ceux-ci
US9505800B2 (en) 2006-11-03 2016-11-29 Myrexis, Inc. Extended triterpene derivatives
ES2437331T3 (es) * 2007-07-12 2014-01-10 Janssen R&D Ireland Forma cristalina de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]-2-pirimidinil]amino]benzonitrilo
MX2010007375A (es) 2008-01-03 2010-09-30 Virochem Pharma Inc Nuevos derivados de lupano.
WO2009082818A1 (fr) 2008-01-03 2009-07-09 Virochem Pharma Inc. Préparation de nouveaux dérivés de c-21-céto lupane et leur utilisation
DE102008037025C5 (de) * 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
US8778990B2 (en) 2008-11-04 2014-07-15 Trustees Of Dartmouth College Betulinic acid derivatives and methods of use thereof
CZ301318B6 (cs) 2008-11-13 2010-01-13 Univerzita Palackého v Olomouci 2-Deoxyglykosidy triterpenoidu, zpusob jejich prípravy a jejich použití jako lécivo
BRPI0923217A2 (pt) * 2008-12-11 2017-05-23 Glaxosmithkline Llc processos para a preparação de um composto de piridona, e para a preparação de uma forma cristalina, composto, sal ou um hidrato deste, forma cristalina de um sal de sódio ou um hidrato deste, e, composição farmacêutica.
US8802727B2 (en) 2009-07-14 2014-08-12 Hetero Research Foundation, Hetero Drugs Limited Pharmaceutically acceptable salts of betulinic acid derivatives
US9067966B2 (en) 2009-07-14 2015-06-30 Hetero Research Foundation, Hetero Drugs Ltd. Lupeol-type triterpene derivatives as antivirals
EA201290632A1 (ru) * 2010-02-11 2013-03-29 ГЛАКСОСМИТКЛАЙН ЭлЭлСи Производные бетулина
TWI577377B (zh) * 2010-09-16 2017-04-11 Ｖｉｉｖ醫療保健公司 醫藥組合物
WO2013020245A1 (fr) 2011-08-08 2013-02-14 Glaxosmithkline Llc Dérivés carbonyles de bétuline
WO2013020246A1 (fr) 2011-08-08 2013-02-14 Glaxosmithkline Llc Dérivés méthylènes de bétuline
EP2791102B1 (fr) 2011-12-14 2016-05-18 Glaxosmithkline LLC Dérivés propénoate de la bétuline
JO3387B1 (ar) * 2011-12-16 2019-03-13 Glaxosmithkline Llc مشتقات بيتولين
WO2014035945A1 (fr) 2012-08-28 2014-03-06 Glaxosmithkline Llc Compositions pharmaceutiques
KR20150093819A (ko) * 2012-12-14 2015-08-18 글락소스미스클라인 엘엘씨 약제 조성물
MX2017003928A (es) 2014-09-26 2017-06-28 Glaxosmithkline Intellectual Property (No 2) Ltd Composiciones farmaceuticas de accion prolongada.

Also Published As

Publication number Publication date
CL2015001660A1 (es) 2015-10-02
US20180042944A1 (en) 2018-02-15
EP2931285A4 (fr) 2016-06-01
PE20151326A1 (es) 2015-10-12
EA201590862A1 (ru) 2016-05-31
CN104902905A (zh) 2015-09-09
AU2013358897A1 (en) 2015-07-02
AU2013358897B2 (en) 2017-01-05
US20150313917A1 (en) 2015-11-05
SG11201503807TA (en) 2015-06-29
CA2893959A1 (fr) 2014-06-19
SG10201704467SA (en) 2017-06-29
WO2014093941A1 (fr) 2014-06-19
MA38182A1 (fr) 2018-04-30
US9795619B2 (en) 2017-10-24
KR20150093819A (ko) 2015-08-18
JP2016503030A (ja) 2016-02-01
BR112015013695A2 (pt) 2017-07-11
EP2931285A1 (fr) 2015-10-21
ZA201503594B (en) 2018-11-28
IL238807A0 (en) 2015-06-30
PH12015501156A1 (en) 2015-08-10
MX2015007563A (es) 2015-10-14
CR20150313A (es) 2015-10-19

Similar Documents

Publication Publication Date Title
IL286348A (en) Pharmaceutical preparations that include allopregnanolone
HK1209638A1 (en) Pharmaceutical compositions
ZA201501930B (en) Pharmaceutical composition
GB201113662D0 (en) Pharmaceutical compositions
ZA201308208B (en) Pharmaceutical compositions
HK1203812A1 (en) Novel pharmaceutical formulations
HK1199824A1 (en) Pharmaceutical compositions
EP2832730A4 (fr) Composition pharmaceutique contenant du mirabegron
IL266415A (en) Innovative pharmaceutical composition
GB201118181D0 (en) Pharmaceutical compositions
ZA201502987B (en) Pharmaceutical composition
EP2897590A4 (fr) Composition pharmaceutique
GB201211153D0 (en) Pharmaceutical compositions
HK1209339A1 (en) Pharmaceutical formulations
EP2851078A4 (fr) Composition pharmaceutique
EP2714715A4 (fr) Compositions pharmaceutiques
IL238075A0 (en) pharmaceutical preparations
GB201219234D0 (en) Pharmaceutical compositions
GB201213303D0 (en) Pharmaceutical compositions
GB201204810D0 (en) Pharmaceutical compositions
ZA201400751B (en) Pharmaceutical composition
GB201221130D0 (en) New pharmaceutical composition
GB201207628D0 (en) New pharmaceutical composition
GB201207701D0 (en) New pharmaceutical composition
GB201211406D0 (en) Pharmaceutical formulations